Прибыль до налогообложения Изменить Дата
Adma Biologics USD 57.13M 4.47M 2026-03
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Bayer EUR 321M 2.67B 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cassava Sciences USD -10.81M 33.41M 2025-09
Cipla INR 10.82B 3.33B 2026-06
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -7.66M 64.51M 2026-03
CSL USD 2.61B 1.21B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
J&J USD 8.66B 839M 2026-06
Merck USD -3.53B 6.95B 2026-03
Pacira USD 5M 4.43M 2026-03
Pfizer USD -653M 5.84B 2026-06
TherapeuticsMD USD -1.05M 241K 2024-06